Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lifecore inks biomaterial deal:

This article was originally published in Clinica

Executive Summary

Lifecore Biomedical has entered into exclusive licence and development agreements with the Cleveland Clinic, in Ohio, to develop and commercialise hyaluronan-based products and related applications. It has licensed a patented hyaluronan-based cross-linking technology that can be used for products in aesthetics, orthopaedics, ophthalmology and other medical fields. The biomaterial is formed through a chemical reaction, catalysed by a naturally occurring molecule, which provides a spectrum of formulations that are stable, well-tolerated by the body, and able to mimic the function of a wide variety of tissues, while providing for tissue repair and reinforcement, said the Chaska, Minnesota firm. Lifecore believes the technology platform will allow it to expand in its existing markets and enter new markets.

You may also be interested in...

Real World Data Failed To Impress Kaftrio’s European Reviewers

The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.

Swissmedic Clears Up Confusion Over Validity Of GMP Certificates

Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.

People On The Move: Appointments At Stada, PGEU, And UK Health Claims Committee

Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts